Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heterogeneity of breast cancer: The importance of interaction between different tumor cell populations
Indrė Januškevičienė, Vilma Petrikaitė
Life Sciences (2019) Vol. 239, pp. 117009-117009
Closed Access | Times Cited: 164

Showing 1-25 of 164 citing articles:

A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer
Vikas Jain, Hitesh Kumar, Haritha V. Anod, et al.
Journal of Controlled Release (2020) Vol. 326, pp. 628-647
Closed Access | Times Cited: 218
The Role of Curcumin in Cancer Treatment
Vasiliki Zoi, Vasiliki Galani, Georgios D. Lianos, et al.
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1086-1086
Open Access | Times Cited: 173
Cancer Stem Cell Plasticity – A Deadly Deal
Archana P. Thankamony, Kritika Saxena, Reshma Murali, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 139
Raman spectroscopy and machine learning for the classification of breast cancers
Lihao Zhang, Chengjian Li, Di Peng, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2021) Vol. 264, pp. 120300-120300
Open Access | Times Cited: 116
New Machine Learning Applications to Accelerate Personalized Medicine in Breast Cancer: Rise of the Support Vector Machines
Mustafa Erhan Ozer, Pemra Özbek, Kazım Yalçın Arğa
OMICS A Journal of Integrative Biology (2020) Vol. 24, Iss. 5, pp. 241-246
Closed Access | Times Cited: 75
Redox-responsive hyaluronic acid-based nanoparticles for targeted photodynamic therapy/chemotherapy against breast cancer
Rujuan Wang, Haotong Yang, Abdur Rauf Khan, et al.
Journal of Colloid and Interface Science (2021) Vol. 598, pp. 213-228
Closed Access | Times Cited: 69
Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer
Liyun Luo, Zhijie Zhang, Ni Qiu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 69
ALKBH5-Mediated m6A Demethylation of GLUT4 mRNA Promotes Glycolysis and Resistance to HER2-Targeted Therapy in Breast Cancer
Hao Liu, Hui Lyu, Guanmin Jiang, et al.
Cancer Research (2022) Vol. 82, Iss. 21, pp. 3974-3986
Open Access | Times Cited: 62
Circular RNAs: New layer of complexity evading breast cancer heterogeneity
Alyaa Dawoud, Z Zakaria, Hannah Hisham Rashwan, et al.
Non-coding RNA Research (2022) Vol. 8, Iss. 1, pp. 60-74
Open Access | Times Cited: 40
Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going
Carlotta Mazzitelli, Donatella Santini, Angelo Gianluca Corradini, et al.
Diagnostics (2023) Vol. 13, Iss. 7, pp. 1241-1241
Open Access | Times Cited: 24
Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance
Guohua Li, Qiang Qu, Tingting Qi, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 53
A Systematic Review of PET Textural Analysis and Radiomics in Cancer
Manuel Piñeiro-Fiel, Alexis Moscoso, Virginia Pubul, et al.
Diagnostics (2021) Vol. 11, Iss. 2, pp. 380-380
Open Access | Times Cited: 47
Immunotherapy in Breast Cancer: When, How, and What Challenges?
Beatriz Carvalho Henriques, Fernando Mendes, Diana Martins
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1687-1687
Open Access | Times Cited: 47
Cooperation between Angiogenesis, Vasculogenesis, Chemotaxis, and Coagulation in Breast Cancer Metastases Development: Pathophysiological Point of View
Elżbieta Zarychta, Barbara Ruszkowska-Ciastek
Biomedicines (2022) Vol. 10, Iss. 2, pp. 300-300
Open Access | Times Cited: 33
Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer
Yasmin Dekker, Sylvia E. Le Dévédec, Erik H.J. Danen, et al.
Genes (2022) Vol. 13, Iss. 9, pp. 1585-1585
Open Access | Times Cited: 33
Identification of Novel Natural Dual HDAC and Hsp90 Inhibitors for Metastatic TNBC Using e-Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Studies
Nihal Abdelmoniem, Marwa H. Abdallah, Rua M. Mukhtar, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1771-1771
Open Access | Times Cited: 20
Single-Cell Transcriptome Analysis Revealed Heterogeneity and Identified Novel Therapeutic Targets for Breast Cancer Subtypes
Radhakrishnan Vishnubalaji, Nehad M. Alajez
Cells (2023) Vol. 12, Iss. 8, pp. 1182-1182
Open Access | Times Cited: 20
microRNA-944 inhibits breast cancer cell proliferation and promotes cell apoptosis by reducing SPP1 through inactivating the PI3K/Akt pathway
Ying Zhang, Shan Li, Xiangguo Cui, et al.
APOPTOSIS (2023) Vol. 28, Iss. 11-12, pp. 1546-1563
Closed Access | Times Cited: 19
Analyses of hypoxia-related risk factors and clinical relevance in breast cancer
Yan Li, Haiyang Yu, Xinghua Han, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
The immune regulation and therapeutic potential of the SMAD gene family in breast cancer
Zhuo Chen, Yu Wang, Xiaodi Lu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Applicability of Quantum Dots in Breast Cancer Diagnostic and Therapeutic Modalities—A State-of-the-Art Review
Dominika Kunachowicz, Karolina Kłosowska, N. Sobczak, et al.
Nanomaterials (2024) Vol. 14, Iss. 17, pp. 1424-1424
Open Access | Times Cited: 6
MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
Sadia Choudhery, Daniel Gomez‐Cardona, Christopher Favazza, et al.
Academic Radiology (2020) Vol. 29, pp. S145-S154
Open Access | Times Cited: 48
Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease
Amal Qattan
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 8905-8905
Open Access | Times Cited: 45
Small nucleolar RNA and its potential role in breast cancer – A comprehensive review
Venzil Lavie Dsouza, Divya Adiga, S. Sriharikrishnaa, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1875, Iss. 1, pp. 188501-188501
Closed Access | Times Cited: 35
Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer
Zheqiong Tan, Yaru Zou, Man Zhu, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top